Correlation Between Aethlon Medical and Neuropace
Can any of the company-specific risk be diversified away by investing in both Aethlon Medical and Neuropace at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aethlon Medical and Neuropace into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aethlon Medical and Neuropace, you can compare the effects of market volatilities on Aethlon Medical and Neuropace and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aethlon Medical with a short position of Neuropace. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aethlon Medical and Neuropace.
Diversification Opportunities for Aethlon Medical and Neuropace
-0.31 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Aethlon and Neuropace is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Aethlon Medical and Neuropace in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuropace and Aethlon Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aethlon Medical are associated (or correlated) with Neuropace. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuropace has no effect on the direction of Aethlon Medical i.e., Aethlon Medical and Neuropace go up and down completely randomly.
Pair Corralation between Aethlon Medical and Neuropace
Given the investment horizon of 90 days Aethlon Medical is expected to under-perform the Neuropace. But the stock apears to be less risky and, when comparing its historical volatility, Aethlon Medical is 1.93 times less risky than Neuropace. The stock trades about -0.06 of its potential returns per unit of risk. The Neuropace is currently generating about 0.27 of returns per unit of risk over similar time horizon. If you would invest 620.00 in Neuropace on September 19, 2024 and sell it today you would earn a total of 532.00 from holding Neuropace or generate 85.81% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Aethlon Medical vs. Neuropace
Performance |
| Timeline |
| Aethlon Medical |
| Neuropace |
Aethlon Medical and Neuropace Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aethlon Medical and Neuropace
The main advantage of trading using opposite Aethlon Medical and Neuropace positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aethlon Medical position performs unexpectedly, Neuropace can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuropace will offset losses from the drop in Neuropace's long position.| Aethlon Medical vs. Tivic Health Systems | Aethlon Medical vs. Bluejay Diagnostics | Aethlon Medical vs. Heart Test Laboratories | Aethlon Medical vs. Nuwellis |
| Neuropace vs. Electromed | Neuropace vs. Orthopediatrics Corp | Neuropace vs. SurModics | Neuropace vs. Paragon 28 |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |